How should I manage a patient with low serum iron, normal-to-high ferritin, elevated C-reactive protein, low complement C3, borderline complement C4, elevated thyroid‑stimulating hormone, low free thyroxine, and EBV serology indicating past infection?

Management Approach

This patient has functional iron deficiency (anemia of chronic disease) with concurrent inflammation, subclinical hypothyroidism, and past EBV infection—the priority is to identify and treat the underlying inflammatory condition driving these abnormalities, while simultaneously initiating thyroid hormone replacement and addressing iron deficiency with intravenous iron if symptomatic.

Understanding the Laboratory Pattern

Your patient presents with a classic pattern of anemia of chronic disease (ACD) combined with true iron deficiency:

• Low serum iron (23) with elevated ferritin (307) and elevated CRP (16.80) indicates functional iron deficiency in the setting of active inflammation 1
• The ferritin >100 μg/L with low serum iron suggests iron is sequestered in stores but unavailable for erythropoiesis due to inflammation 1
• Low complement C3 (244) combined with elevated CRP points toward active systemic inflammation or possible autoimmune disease 2, 3
• Elevated TSH (7.35) with low-normal T4 (1.11) indicates subclinical to overt hypothyroidism
• EBV serology (VCA IgG positive, EBNA positive, IgM negative at 4.4) indicates past infection, not acute disease

Diagnostic Interpretation Framework

Iron Status in Inflammation

In the presence of biochemical inflammation (CRP 16.80), ferritin >100 μg/L does NOT exclude iron deficiency 1. The diagnostic criteria shift:

• Ferritin 30-100 μg/L = likely mixed iron deficiency + ACD
• Ferritin >100 μg/L with transferrin saturation <16% = ACD likely
• Your patient needs transferrin saturation measurement to complete the iron assessment 1, 4

The Inflammation-Thyroid-Iron Connection

The elevated CRP with low C3 is concerning and requires investigation. Research shows:

• Iron deficiency can impair thyroid hormone metabolism 5, 6
• Ferritin correlates with complement C3 levels 2
• Low C3 with elevated ferritin and CRP suggests active systemic inflammation, possibly autoimmune 3

Immediate Management Algorithm

Step 1: Complete the Workup (Within 1-2 Weeks)

Essential additional tests:

• Complete blood count with MCV, MCH, hemoglobin
• Transferrin saturation (TIBC and serum iron binding capacity)
• Soluble transferrin receptor (sTfR) if available—helps distinguish true iron deficiency from pure ACD 1
• Reticulocyte hemoglobin content (CHr) if available 7
• Free T4 and free T3 (your T4 of 1.11 needs context—is this total or free?)
• Anti-TPO and anti-thyroglobulin antibodies (hypothyroidism + inflammation suggests Hashimoto's) 8, 6
• ANA, anti-dsDNA, complement C4 repeat (low C3 with inflammation raises concern for lupus or other autoimmune disease) 9

Investigate the source of inflammation:

• If gastrointestinal symptoms or risk factors: upper endoscopy with small bowel biopsies (to exclude celiac disease) and colonoscopy 4, 10
• Screen for occult blood loss if anemic 4
• Consider rheumatologic evaluation if complement abnormalities persist

Step 2: Treat the Thyroid (Immediately)

TSH 7.35 with low-normal T4 warrants thyroid hormone replacement:

• Start levothyroxine 1.6 mcg/kg/day (or 50-75 mcg daily if elderly/cardiac disease)
• Recheck TSH and free T4 in 6-8 weeks
• Iron deficiency impairs thyroid hormone synthesis, so correcting iron status may improve thyroid function 5, 6

Critical caveat: Iron supplementation should be separated from levothyroxine by at least 4 hours to avoid absorption interference.

Step 3: Address Iron Deficiency

If transferrin saturation <16% or patient is symptomatic (fatigue, reduced exercise tolerance):

• Oral iron (ferrous sulfate 100-200 mg elemental iron daily) is first-line if:

  • Mild symptoms
  • No malabsorption
  • Patient can tolerate GI side effects 1

• Intravenous iron (ferric carboxymaltose or iron sucrose) is preferred if:

  • Moderate-severe symptoms affecting quality of life
  • Inflammatory bowel disease or malabsorption
  • Intolerance to oral iron
  • Need for rapid repletion 1, 11

Target ferritin 100-300 μg/L in the setting of chronic inflammation 1. Avoid ferritin >800 μg/L (toxic) 1.

Step 4: Treat the Underlying Inflammation

This is the most critical step for long-term management:

• The combination of elevated CRP, low C3, and functional iron deficiency suggests an active inflammatory or autoimmune process
• Treating the underlying condition is the first step in treating anemia 1
• Common causes to investigate:
  • Autoimmune disease (lupus, rheumatoid arthritis, inflammatory bowel disease)
  • Chronic infection (though EBV is past, not active)
  • Malignancy (less likely with this pattern but consider if age-appropriate)
  • Celiac disease (common cause of iron deficiency with malabsorption) 4

Monitoring Strategy

Short-term (8-12 weeks):

• Repeat CBC, iron studies, ferritin, CRP
• TSH and free T4
• Assess symptom improvement (fatigue, exercise tolerance)

Long-term (every 6-12 months):

• Monitor for anemia recurrence (>50% recur within 1 year if inflammation persists) 1
• Maintain ferritin 100-300 μg/L in inflammatory conditions 1
• Annual vitamin B12 and folate if macrocytosis develops 1

Common Pitfalls to Avoid

1. Don't assume normal iron stores based on ferritin >100 in the setting of inflammation—ferritin is an acute phase reactant and can be falsely elevated 1, 10

2. Don't ignore the low C3—this is not a typical finding in simple iron deficiency or hypothyroidism and warrants autoimmune workup 2, 3

3. Don't treat iron deficiency alone without addressing the underlying inflammatory condition—anemia will recur 1

4. Don't overlook gastrointestinal investigation—even without overt bleeding, occult GI blood loss is the most common cause of iron deficiency in adults 4

5. Don't delay thyroid replacement—TSH >7 with symptoms warrants treatment, and iron deficiency may worsen thyroid function 5, 6